Select a Meeting...
- SHM Converge 2025
- SHM Converge 2024
- SHM Converge 2023
- SHM Converge 2022
- SHM Converge 2021
- Hospital Medicine 2020, Virtual Competition
- Hospital Medicine 2019, March 24-27, National Harbor, Md.
- Hospital Medicine 2018; April 8-11; Orlando, Fla.
- Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
- Hospital Medicine 2016, March 6-9, San Diego, Calif.
- Hospital Medicine 2015, March 29-April 1, National Harbor, Md.
- Hospital Medicine 2014, March 24-27, Las Vegas, Nev.
- Hospital Medicine 2013, May 16-19, National Harbor, Md.
- Hospital Medicine 2012, April 1-4, San Diego, Calif.
- Hospital Medicine 2011, May 10-13, Dallas, Texas.
- Hospital Medicine 2010, April 8-11, Washington, D.C.
- Hospital Medicine 2009, May 14-17, Chicago, Ill.
- Hospital Medicine 2008, April 3-5, San Diego, Calif.
- Hospital Medicine 2007, May 23-25, Dallas, Texas
- Hospital Medicine 2006, May 3-5, Washington, D.C.
Meetings Archive For Hospital Medicine 2020, Virtual Competition..
Abstract Number: 146
Hospital Medicine 2020, Virtual Competition
Background: Readmission and length of stay are two hospital level metrics commonly used to assess the performance of hospitalist groups. Health care systems implement strategies aimed at reducing both. It is possible however that tactics aimed at improving one measure in individual patients may adversely impact the other. Studies in focused populations of patients hospitalized [...]
Abstract Number: 147
Hospital Medicine 2020, Virtual Competition
Background: The 2016 Surviving Sepsis Campaign guidelines recommend antibiotic administration within 1 hour of emergency department (ED) presentation for patients with sepsis. While early antibiotics are associated with reduced mortality, the 1 hr policy has been criticized for its one-size-fits-all approach and risk for over-diagnosis and treatment. Clinicians and quality leaders have called, instead, for [...]
Abstract Number: 148
Hospital Medicine 2020, Virtual Competition
Background: Health care equity, one of the six domains of high-quality health care as defined by the Institute of Medicine, will only be achieved when health care outcomes do not vary based on patient social characteristics, such as gender, race, ethnicity, geographic location, and socioeconomic status. Readmission is a significant outcome for patients and health [...]
Abstract Number: 149
Hospital Medicine 2020, Virtual Competition
Background: While delirium may affect patients of any age, delirium initiatives have focused mostly on the elderly, as older patients are more vulnerable to developing delirium. Few studies have reported delirium in patients between 18-64 years of age, mostly restricted to patients with advanced cancer or on palliative care units. There is a lack of [...]
Abstract Number: 150
Hospital Medicine 2020, Virtual Competition
Background: Patients with immune-mediated diseases such as rheumatoid arthritis, psoriatic arthritis, or inflammatory bowel disease (IBD) are increasingly being prescribed biologics. While biologics may account for roughly 2% of total prescriptions in the United States, they account for over 35% of net drug spending and for over 80% of the growth in net drug spending.1,2 [...]
Abstract Number: 151
Hospital Medicine 2020, Virtual Competition
Background: Type 2 diabetes (T2DM) is a growing epidemic and now the 7th leading cause of death (1). Despite new advances in medications and technology more than 50% of adults with diabetes in the U.S still don’t achieve the recommended goal of glycated hemoglobin (HbA1c) level of 7.0% or less (2).Local Problem : Hispanics with [...]
Abstract Number: 152
Hospital Medicine 2020, Virtual Competition
Background: Pulmonary arterial hypertension (PAH) is a progressively debilitating disorder characterized by sustained increases in pulmonary vascular resistance and pulmonary arterial pressure, which eventually leads to right-sided heart failure. Current therapies for PAH work predominately as vasodilators to target symptoms, rather than focusing on the initial signals that promote disease progression. These therapies have proved [...]
Abstract Number: 153
Hospital Medicine 2020, Virtual Competition
Background: Acute pancreatitis (AP) is a sudden inflammation of the pancreas, and biliary pancreatitis remains the most common cause of AP. Endoscopic retrograde cholangiopancreatography (ERCP) is very commonly used in AP with coexisting acute cholangitis or biliary obstruction. There was a need for a nationwide study to evaluate ERCP utilization trends and healthcare costs amongst [...]
Abstract Number: 154
Hospital Medicine 2020, Virtual Competition
Background: Increased risk of venous thromboembolism (VTE) has been noted among cancer patients as compared to non-cancer. Cancer associated thrombosis caused three folds increased hospitalizations, increased inpatient/outpatient medical and prescription claims, and increased total health care costs per patient. Our objective was to study demographic, clinical and laboratory risk factors for venous thromboembolism (VTE) among [...]
Abstract Number: 155
Hospital Medicine 2020, Virtual Competition
Background: After discharge from an acute care hospitalization, cancer patients may choose to pursue rehabilitative care in a skilled nursing facility (SNF). Our objective was to examine receipt of anti-cancer therapy, death, readmission, and hospice use of cancer patients who discharge to a SNF compared to those who discharge home or home with home health [...]